United States · Investor

BioFrontier Partners

Last cheque observed Feb 2005. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series CSeries BSeries DLife Science

Cheques on record
0%of best year0cheques in 12 months, 5 on record
Since the last cheque7910days00hrs00min00sec
Median round$30MRounds led0 of 5Exits1 from the portfolioMostly inUnited States, 80%
Pitch BioFrontier Partners

BioFrontier Partners highlights

  1. 01

    5 rounds on record

  2. 02

    Mostly Series C and Series B: 60% of its rounds

  3. 03

    1 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
Life Science
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first5 appearances

  1. 2005

    1 round

  2. Feb
    Perlegen SciencesSeries D · US · allbusiness.com$74MWith 14 others
  3. 2004

    1 round

  4. Jan
    BioTroveSeries B · US$11MWith 3 others
  5. 2003

    3 rounds

  6. Mar
    CellZomeVenture · DE$32MWith 5 others
  7. Jan
    Perlegen SciencesSeries C · US$30MWith 8 others
  8. Jan
    CardioNetSeries C · US$13MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

BioTroveBought by Life TechnologiesUndisclosedNov 2009

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as BioFrontier Partners. A count of rooms they were both in, not a relationship either has claimed.

CMEA VenturesVC firm2rounds togetherCSK Venture CapitalVC firm2rounds togetherMaverick CapitalVC firm2rounds togetherSB Life ScienceGrowth equity2rounds together

Quick answers about BioFrontier Partners

What does BioFrontier Partners invest in?

BioFrontier Partners invests most often at Series C and Series B (60% of the rounds on record), in sectors such as Life Science.

How active is BioFrontier Partners?

5 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2005.

How big are BioFrontier Partners's cheques?

The median round it joins is $30M.

Does BioFrontier Partners lead rounds?

Rarely, if at all: none of its 5 investments on record names it as the lead.

Where does BioFrontier Partners invest?

Most of the companies it backs are in the United States (80%) and Germany (20%).

Is BioFrontier Partners investing now?

No investments in the last 12 months; the latest was in Feb 2005.

Who does BioFrontier Partners invest alongside?

Most often CMEA Ventures (2 rounds together), CSK Venture Capital (2 rounds together) and Maverick Capital (2 rounds together).

What kind of investor is BioFrontier Partners?

BioFrontier Partners is a VC firm based in United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it